Patent · US Active

Compositions comprising citrulline and leucine and their use in the treatment of diabetes and metabolic syndrome

US11419838B2 · kind B2 · utility

0Cited by

1References

9Claims

0Family size

Assignee

Societe des Produits Nestle S.A. · CH

Inventors

Christophe Moinard · Bourg-la-Reine, FR
Gabrielle Ventura · Paris, FR
Denis Breuille · Saint-Saturnin, FR
Christian Darimont-Nicolau · Lausanne, CH
Luc Cynober · Sceaux, FR

Key dates

Filing date	Feb 8, 2018
Grant date	Aug 23, 2022
Priority date	—
Expiry date	Nov 12, 2038

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P43/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Compositions contain citrulline and leucine or a metabolite thereof including, for example, a synergistic amount of citrulline and leucine. Such compositions may be used in methods for the treatment of pre-diabetes, metabolic syndrome, hyperglycemia, or diabetes.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.